The mutational landscape of a prion-like domain
Open Access
- 13 September 2019
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-12
Abstract
Insoluble protein aggregates are the hallmarks of many neurodegenerative diseases. For example, aggregates of TDP-43 occur in nearly all cases of amyotrophic lateral sclerosis (ALS). However, whether aggregates cause cellular toxicity is still not clear, even in simpler cellular systems. We reasoned that deep mutagenesis might be a powerful approach to disentangle the relationship between aggregation and toxicity. We generated >50,000 mutations in the prion-like domain (PRD) of TDP-43 and quantified their toxicity in yeast cells. Surprisingly, mutations that increase hydrophobicity and aggregation strongly decrease toxicity. In contrast, toxic variants promote the formation of dynamic liquid-like condensates. Mutations have their strongest effects in a hotspot that genetic interactions reveal to be structured in vivo, illustrating how mutagenesis can probe the in vivo structures of unstructured proteins. Our results show that aggregation of TDP-43 is not harmful but protects cells, most likely by titrating the protein away from a toxic liquid-like phase.Keywords
All Related Versions
This publication has 75 references indexed in Scilit:
- Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease modelsNature Genetics, 2012
- Direct Observation of the Interconversion of Normal and Toxic Forms of α-SynucleinCell, 2012
- The Amyloid State of Proteins in Human DiseasesCell, 2012
- Opposing Effects of Glutamine and Asparagine Govern Prion Formation by Intrinsically Disordered ProteinsMolecular Cell, 2011
- Intrinsic Protein Disorder and Interaction Promiscuity Are Widely Associated with Dosage SensitivityCell, 2009
- Misfolded proteins partition between two distinct quality control compartmentsNature, 2008
- A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicityProceedings of the National Academy of Sciences, 2008
- TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's diseaseAnnals of Neurology, 2007
- Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal deathNature, 2004
- Rationalization of the effects of mutations on peptide andprotein aggregation ratesNature, 2003